Doxorubicin-Based Hybrid Compounds as Potential Anticancer Agents: A Review

The scarcity of novel and effective therapeutics for the treatment of cancer is a pressing and alarming issue that needs to be prioritized. The number of cancer cases and deaths are increasing at a rapid rate worldwide. Doxorubicin, an anticancer agent, is currently used to treat several types of ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Peter, Sijongesonke, Alven, Sibusiso, Maseko, Rejoice Bethusile, Aderibigbe, Blessing Atim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318127/
https://www.ncbi.nlm.nih.gov/pubmed/35889350
http://dx.doi.org/10.3390/molecules27144478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318127/
https://www.ncbi.nlm.nih.gov/pubmed/35889350
http://dx.doi.org/10.3390/molecules27144478

Ejemplares similares